Previous close | 0.0400 |
Open | 0.0800 |
Bid | 0.0200 |
Ask | 0.1100 |
Strike | 4.50 |
Expiry date | 2024-05-24 |
Day's range | 0.0800 - 0.1100 |
Contract range | N/A |
Volume | |
Open interest | 266 |
Peloton isn't profitable as a subscription business, but it looks different as a media company.
Amgen is the latest biotech to benefit from obesity drug optimism, Sony and Apollo offer Paramount Global $26 billion cash in takeover move, and other news to start your day.
Amidst leadership transitions and market adjustments, Peloton reports a significant quarter with strategic restructuring and a focus on sustainable growth.